
Sign up to save your podcasts
Or


Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
651651 ratings
Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,863 Listeners

1,721 Listeners

965 Listeners

4,385 Listeners

402 Listeners

432 Listeners

1,658 Listeners

1,450 Listeners

1,051 Listeners

1,306 Listeners

6,095 Listeners

1,578 Listeners

211 Listeners

1,324 Listeners

589 Listeners

151 Listeners

89 Listeners

76 Listeners

141 Listeners